AngioDynamics
ANGO
10.81
+0.05
+0.46%
AngioDynamics
US · ANGO
#3631 by market cap
10.81
+0.05
+0.46%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Recent news
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2024/12/10
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/10/14
-
Rating change
Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24Market Newswire · 2026/1/7
-
Rating change
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2025/1/10
-
Company notice
Global Ltd: Notice of the opening of Kyoto 5 property Hotel Group Project "ENSO ANGO"JPX · 2018/10/16
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2025/4/8
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2025/1/10
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18Market Newswire · 2026/1/7
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/7/16
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $18Market Newswire · 2025/10/3
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $19Market Newswire · 2026/7/16
-
Rating change
CCORF Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $15Market Newswire · 2025/1/10
-
Rating change
Freedom Capital Markets Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $16Market Newswire · 2026/4/6
-
Company notice
Global Ltd: Notice on the change of the name of "ENSO ANGO" of Metropole HotelJPX · 2020/2/28
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)TipRanks · 2026/5/29
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18Market Newswire · 2026/10/14
-
Lake Street Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $24Market Newswire · 2026/7/14
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2025/8/13
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2024/12/10
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/4/6
-
Rating change
AngioDynamics (ANGO) Gets a Buy From H.C. WainwrightTipRanks · 2024/10/4
-
Rating change
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2024/10/5
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12Market Newswire · 2024/10/4
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:01:15 · For reference only, not investment advice and not tailored to your situation.
AngioDynamics discussion 0 comments